Ligand-Modified Human Serum Albumin Nanoparticles for Enhanced Gene Delivery

Molecular Pharmaceutics

Volumn 12, Issue 9, 2015, Pages 3202-3213

  Look, Jennifer ^a   Wilhelm, Nadine ^b   Von Briesen, Hagen ^b   Noske, Nadja ^c   Günther, Christine ^c   Langer, Klaus ^a   Gorjup, Erwin ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b FRAUNHOFER INSTITUTE FOR BIOMEDICAL ENGINEERING   (Germany)

^c Apceth GmbH and Co KG   (Germany)

Author keywords

albumin; gene delivery; human mesenchymal stem cell; modification; nanoparticle

Indexed keywords

ARGININE; ARGINYLGLYCYLASPARTIC ACID; ASPARTIC ACID; GLYCINE; HUMAN SERUM ALBUMIN; HUMAN SERUM ALBUMIN NANOPARTICLE; LIGAND; NANOPARTICLE; PLASMID DNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; ARGINYL-GLYCYL-ASPARTYL-CYSTEINE; CROSS LINKING REAGENT; OLIGOPEPTIDE; SERUM ALBUMIN;

AMINO ACID SEQUENCE; ARTICLE; CELL INTERACTION; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSS LINKING; DEACETYLATION; DNA CONTENT; EX VIVO GENE TRANSFER; FOLLOW UP; FREEZE DRYING; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; MESENCHYMAL STEM CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; REPORTER GENE; SURFACE CHARGE; SURFACE PROPERTY; ZETA POTENTIAL; CHEMISTRY; FLOW CYTOMETRY; GENE TRANSFER; GENETICS; HEK293 CELL LINE;

CROSS-LINKING REAGENTS; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; HEK293 CELLS; HUMANS; LIGANDS; NANOPARTICLES; OLIGOPEPTIDES; SERUM ALBUMIN; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSFECTION;

EID: 84941097015     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.5b00153     Document Type: Article

References (47)

1. Chen, C. Y.; Chang, Y. N.; Ryan, P.; Linscott, M.; McGarrity, G. J.; Chiang, Y. L. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect" Hum. Gene Ther. 1995, 6 (11) 1467-76 10.1089/hum.1995.6.11-1467
2. Niess, H.; Bao, Q.; Conrad, C.; Zischek, C.; Notohamiprodjo, M.; Schwab, F.; Schwarz, B.; Huss, R.; Jauch, K. W.; Nelson, P. J.; Bruns, C. J. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma Ann. Surg. 2011, 254 (5) 767-74 (discussion 774-5) 10.1097/SLA.0b013e3182368c4f
3. Yang, K.; Xu, W. G.; Liu, Y. Z.; Meng, X. R.; Chen, P.; Wu, L. C. Study on the effect of BMSCs-EGFP-tk as mediator of HSV1-tk/GCV suicide gene therapy directed against A549 in vitro Int. J. Clin Exp Med. 2014, 7 (9) 3080-6
4. Uchibori, R.; Okada, T.; Ito, T.; Urabe, M.; Mizukami, H.; Kume, A.; Ozawa, K. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy J. Gene Med. 2009, 11 (5) 373-81 10.1002/jgm.1313
5. Hamm, A.; Krott, N.; Breibach, I.; Blindt, R.; Bosserhoff, A. K. Efficient transfection method for primary cells Tissue Eng. 2002, 8 (2) 235-45 10.1089/107632702753725003
6. Marx, J. C.; Allay, J. A.; Persons, D. A.; Nooner, S. A.; Hargrove, P. W.; Kelly, P. F.; Vanin, E. F.; Horwitz, E. M. High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells Hum. Gene Ther. 1999, 10 (7) 1163-73 10.1089/10430349950018157
7. Scharfmann, R.; Axelrod, J. H.; Verma, I. M. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants Proc. Natl. Acad. Sci. U. S. A. 1991, 88 (11) 4626-30 10.1073/pnas.88.11.4626
8. Boulaiz, H.; Marchal, J. A.; Prados, J.; Melguizo, C.; Aranega, A. Non-viral and viral vectors for gene therapy Cell Mol. Biol. (Noisy-le-grand) 2005, 51 (1) 3-22
9. Check, E. A tragic setback Nature 2002, 420 (6912) 116-8 10.1038/420116a
10. Gordon, J. W. High toxicity, low receptor density, and low integration frequency severely impede the use of adenovirus vectors for production of transgenic mice Biol. Reprod. 2002, 67 (4) 1172-9 10.1095/biolreprod67.4.1172
11. Sun, J. Y.; Anand-Jawa, V.; Chatterjee, S.; Wong, K. K. Immune responses to adeno-associated virus and its recombinant vectors Gene Ther. 2003, 10 (11) 964-76 10.1038/sj.gt.3302039
12. Teramoto, S.; Johnson, L. G.; Huang, W.; Leigh, M. W.; Boucher, R. C. Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells Hum. Gene Ther. 1995, 6 (8) 1045-53 10.1089/hum.1995.6.8-1045
13. Zaiss, A. K.; Muruve, D. A. Immune responses to adeno-associated virus vectors Curr. Gene Ther. 2005, 5 (3) 323-31 10.2174/1566523054065039
14. Zhong, H.; He, Z. G.; Li, Z.; Li, G.-Y.; Shen, S.-R.; Li, X.-L. Studies on polyamidoamine dendrimers as efficient gene delivery vector J. Biomater. Appl. 2008, 22 (6) 527-44 10.1177/0885328207080005
15. Kwoh, D. Y.; Coffin, C. C.; Lollo, C. P.; Jovenal, J.; Banaszczyk, M. G.; Mullen, P.; Phillips, A.; Amini, A.; Fabrycki, J.; Bartholomew, R. M.; Brostoff, S. W.; Carlo, D. J. Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver Biochim. Biophys. Acta, Gene Struct. Expression 1999, 1444 (2) 171-90 10.1016/S0167-4781(98)00274-7
16. Zhdanov, R. I.; Podobed, O. V.; Vlassov, V. V. Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy Bioelectrochemistry 2002, 58 (1) 53-64 10.1016/S1567-5394(02)00132-9
17. Kneuer, C.; Sameti, M.; Haltner, E. G.; Schiestel, T.; Schirra, H.; Schmidt, H.; Lehr, C. M. Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA Int. J. Pharm. 2000, 196 (2) 257-61 10.1016/S0378-5173(99)00435-4
18. Toncheva, V.; Wolfert, M. A.; Dash, P. R.; Oupicky, D.; Ulbrich, K.; Seymour, L. W.; Schacht, E. H. Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers Biochim. Biophys. Acta, Gen. Subj. 1998, 1380 (3) 354-68 10.1016/S0304-4165(98)00004-X
19. Zintchenko, A.; Susha, A. S.; Concia, M.; Feldmann, J.; Wagner, E.; Rogach, A. L.; Ogris, M. Drug nanocarriers labeled with near-infrared-emitting quantum dots (quantoplexes): imaging fast dynamics of distribution in living animals Mol. Ther. 2009, 17 (11) 1849-56 10.1038/mt.2009.201
20. Kang, H. C.; Lee, M.; Bae, Y. H. Polymeric gene carriers Crit. Rev. Eukaryotic Gene Expression 2005, 15 (4) 317-42 10.1615/CritRevEukarGeneExpr.v15.i4.30
21. Lee, M.; Kim, S. W. Polyethylene glycol-conjugated copolymers for plasmid DNA delivery Pharm. Res. 2005, 22 (1) 1-10 10.1007/s11095-004-9003-5
22. Rubino, O. P.; Kowalsky, R.; Swarbrick, J. Albumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking, and drug release Pharm. Res. 1993, 10 (7) 1059-65 10.1023/A:1018979126326
23. Wartlick, H.; Spankuch-Schmitt, B.; Strebhardt, K.; Kreuter, J.; Langer, K. Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles J. Controlled Release 2004, 96 (3) 483-95 10.1016/j.jconrel.2004.01.029
24. Watcharin, W.; Schmithals, C.; Pleli, T.; Koberle, V.; Korkusuz, H.; Huebner, F.; Zeuzem, S.; Korf, H. W.; Vogl, T. J.; Rittmeyer, C.; Terfort, A.; Piiper, A.; Gelperina, S.; Kreuter, J. Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging Eur. J. Pharm. Biopharm. 2014, 87 (1) 132-41 10.1016/j.ejpb.2013.12.010
25. Gradishar, W. J.; Tjulandin, S.; Davidson, N.; Shaw, H.; Desai, N.; Bhar, P.; Hawkins, M.; O'Shaughnessy, J. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer J. Clin. Oncol. 2005, 23 (31) 7794-803 10.1200/JCO.2005.04.937
26. Torrano, A. A.; Pereira, A. S.; Oliveira, O. N., Jr.; Barros-Timmons, A. Probing the interaction of oppositely charged gold nanoparticles with DPPG and DPPC Langmuir monolayers as cell membrane models Colloids Surf., B 2013, 108, 120-6 10.1016/j.colsurfb.2013.02.014
27. Fischer, D.; Bieber, T.; Brusselbach, S.; Elsasser, H.; Kissel, T. Cationized human serum albumin as a non-viral vector system for gene delivery? Characterization of complex formation with plasmid DNA and transfection efficiency Int. J. Pharm. 2001, 225 (1-2) 97-111 10.1016/S0378-5173(01)00765-7
28. Rhaese, S.; von Briesen, H.; Rubsamen-Waigmann, H.; Kreuter, J.; Langer, K. Human serum albumin-polyethylenimine nanoparticles for gene delivery J. Controlled Release 2003, 92 (1-2) 199-208 10.1016/S0168-3659(03)00302-X
29. Zhou, Q. H.; You, Y. Z.; Wu, C.; Huang, Y.; Oupicky, D. Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro J. Drug Target 2009, 17 (5) 364-73 10.1080/10611860902807046
30. Gojgini, S.; Tokatlian, T.; Segura, T. Utilizing cell-matrix interactions to modulate gene transfer to stem cells inside hyaluronic acid hydrogels Mol. Pharmaceutics 2011, 8 (5) 1582-91 10.1021/mp200171d
31. Eguchi, A.; Akuta, T.; Okuyama, H.; Senda, T.; Yokoi, H.; Inokuchi, H.; Fujita, S.; Hayakawa, T.; Takeda, K.; Hasegawa, M.; Nakanishi, M. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells J. Biol. Chem. 2001, 276 (28) 26204-10 10.1074/jbc.M010625200
32. Nitin, N.; LaConte, L.; Rhee, W. J.; Bao, G. Tat peptide is capable of importing large nanoparticles across nuclear membrane in digitonin permeabilized cells Ann. Biomed. Eng. 2009, 37 (10) 2018-27 10.1007/s10439-009-9768-0
33. Tunnemann, G.; Martin, R. M.; Haupt, S.; Patsch, C.; Edenhofer, F.; Cardoso, M. C. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells FASEB J. 2006, 20 (11) 1775-84 10.1096/fj.05-5523com
34. Suk, J. S.; Suh, J.; Choy, K.; Lai, S. K.; Fu, J.; Hanes, J. Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles Biomaterials 2006, 27 (29) 5143-50 10.1016/j.biomaterials.2006.05.013
35. Oskowitz, A.; McFerrin, H.; Gutschow, M.; Carter, M. L.; Pochampally, R. Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic Stem Cell Res. 2011, 6 (3) 215-25 10.1016/j.scr.2011.01.004
36. Ward, D. F., Jr.; Salasznyk, R. M.; Klees, R. F.; Backiel, J.; Agius, P.; Bennett, K.; Boskey, A.; Plopper, G. E. Mechanical strain enhances extracellular matrix-induced gene focusing and promotes osteogenic differentiation of human mesenchymal stem cells through an extracellular-related kinase-dependent pathway Stem Cells Dev. 2007, 16 (3) 467-80 10.1089/scd.2007.0034
37. Steinhauser, I.; Langer, K.; Strebhardt, K.; Spankuch, B. Uptake of plasmid-loaded nanoparticles in breast cancer cells and effect on Plk1 expression J. Drug Targeting 2009, 17 (8) 627-637 10.1080/10611860903118823
38. von Storp, B.; Engel, A.; Boeker, A.; Ploeger, M.; Langer, K. Albumin nanoparticles with predictable size by desolvation procedure J. Microencapsulation 2012, 29 (2) 138-46 10.3109/02652048.2011.635218
39. Low, K.; Wacker, M.; Wagner, S.; Langer, K.; von Briesen, H. Targeted human serum albumin nanoparticles for specific uptake in EGFR-Expressing colon carcinoma cells Nanomedicine 2011, 7 (4) 454-63 10.1016/j.nano.2010.12.003
40. Park, J. H.; Kwon, S.; Nam, J. O.; Park, R. W.; Chung, H.; Seo, S. B.; Kim, I. S.; Kwon, I. C.; Jeong, S. Y. Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery J. Controlled Release 2004, 95 (3) 579-88 10.1016/j.jconrel.2003.12.020
41. Zhao, Y.; Lin, D.; Wu, F.; Guo, L.; He, G.; Ouyang, L.; Song, X.; Huang, W.; Li, X. Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery Int. J. Mol. Sci. 2014, 15 (10) 17565-76 10.3390/ijms151017565
42. Gronthos, S.; Simmons, P. J.; Graves, S. E.; Robey, P. G. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix Bone 2001, 28 (2) 174-81 10.1016/S8756-3282(00)00424-5
43. Pandita, D.; Santos, J. L.; Rodrigues, J.; Pego, A. P.; Granja, P. L.; Tomas, H. Gene delivery into mesenchymal stem cells: a biomimetic approach using RGD nanoclusters based on poly(amidoamine) dendrimers Biomacromolecules 2011, 12 (2) 472-81 10.1021/bm1012647
44. Guy, J.; Drabek, D.; Antoniou, M. Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy Mol. Biotechnol. 1995, 3 (3) 237-48 10.1007/BF02789334
45. Wei, L.; Yang, Q.; Xiao, L. Tempo-spatially resolved cellular dynamics of human immunodeficiency virus transacting activator of transcription (Tat) peptide-modified nanocargos in living cells Nanoscale 2014, 6 (17) 10207-15 10.1039/C4NR02732A
46. Herce, H. D.; Garcia, A. E. Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes Proc. Natl. Acad. Sci. U. S. A. 2007, 104 (52) 20805-10 10.1073/pnas.0706574105
47. Wilke, M.; Fortunati, E.; van den Broek, M.; Hoogeveen, A. T.; Scholte, B. J. Efficacy of a peptide-based gene delivery system depends on mitotic activity Gene Ther. 1996, 3 (12) 1133-42